Drug firms don’t disclose enough

The editor-in-chief of the New England Journal of Medicine accused three of the largest drug companies of ‘making a mockery‘ of efforts to create transparency in clinical trials, adding that could lead some important medical publications to avoid publishing their studies.

Comments are closed.

Do NOT follow this link or you will be banned from the site!